Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Nutex Health (NUTX) over the last 13 years, with Q3 2025 value amounting to $302000.0.

  • Nutex Health's Capital Expenditures fell 5105.35% to $302000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 3955.82%. This contributed to the annual value of $2.3 million for FY2024, which is 7574.04% down from last year.
  • Latest data reveals that Nutex Health reported Capital Expenditures of $302000.0 as of Q3 2025, which was down 5105.35% from $751000.0 recorded in Q2 2025.
  • In the past 5 years, Nutex Health's Capital Expenditures ranged from a high of $21.7 million in Q2 2021 and a low of -$7.9 million during Q4 2022
  • For the 5-year period, Nutex Health's Capital Expenditures averaged around $3.6 million, with its median value being $1.8 million (2023).
  • In the last 5 years, Nutex Health's Capital Expenditures tumbled by 16723.32% in 2022 and then skyrocketed by 14782.83% in 2024.
  • Over the past 5 years, Nutex Health's Capital Expenditures (Quarter) stood at $11.7 million in 2021, then tumbled by 167.23% to -$7.9 million in 2022, then skyrocketed by 89.52% to -$825655.0 in 2023, then soared by 147.83% to $394897.0 in 2024, then fell by 23.52% to $302000.0 in 2025.
  • Its Capital Expenditures was $302000.0 in Q3 2025, compared to $751000.0 in Q2 2025 and $64000.0 in Q1 2025.